The content on this site is intended for healthcare professionals only
Editor’s Choice for May 2018
Published: 21 May 2018
Views: 2227
Prof Gordon McVie - Founding Editor, ecancer
- Categories:
- Brain & nervous system
- Breast
- Melanoma & skin
- Neuroendocrine
- Ovary & gynaecology
- Prostate & urology
- Nutrition & wellbeing
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Diagnostics
- Epidemiology & prevention
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Vaccines & virus
Related Videos
War in Ukraine: Impacts on the Slovakian cancer care system
Dr Darina Sedláková
11 May 2022
The Lancet Commission on women and cancer
Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg ...
3 Dec 2021
AORTIC 2021: Goals of AORTIC
Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana
21 Oct 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
19 Jul 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Updates on criteria for patient selection and surgical management in advanced ov...
Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA
20 Jan 2021
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020